Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
- Opening ceremony attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Minister for Enterprise, Tourism and Employment, Peter Burke, TD; and Dexcom President and CEO Jake Leach.
-
Official opening marks next chapter for Dexcom’s investment in
Ireland and manufacturing presence inEurope . - Since announcing plans to create 1,000 roles at its Athenry facility in 2024, Dexcom has filled almost 500 positions and will continue recruiting for the remaining roles as the site and production scale over the coming years.
- Official opening, in the week following World Diabetes Day, celebrates the contributions of Dexcom Athenry staff to the CGM manufacturing process and impact on the lives of those living with diabetes.
ATHENRY,

The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Minister for Enterprise, Tourism and Employment, Peter Burke, TD; Dexcom President and CEO Jake Leach; and other senior Dexcom leaders, follows the start of commercial production at Athenry in October. The official opening celebrates Athenry’s transition from construction to commercial manufacturing and establishes the site as an important part of the company’s global manufacturing network.
Discussing Dexcom’s investment in the West of
Dexcom first broke ground on the Athenry facility in January 2024, announcing plans to create more than 1,000 jobs and invest approximately
Jake Leach, President and Chief Executive Officer of Dexcom, said: “The opening of Athenry is an important milestone for Dexcom, establishing our first manufacturing presence in EMEA and reinforcing our long-term commitment to
Supported by the Irish Government through IDA
The official opening of Dexcom Athenry takes place in the week following World Diabetes Day, observed Nov. 14. The opening date was chosen to recognise the diabetes community and celebrate the impact of Dexcom employees on the development and manufacturing of CGM technology. The diabetes community was represented at the opening by Diabetes Ireland, International Diabetes Federation Europe and Thriveabetes. Norah Casey, an Irish businesswoman and entrepreneur, also spoke at the event, sharing “A Letter to Diabetes,” a personal reflection on her life with diabetes.
Columba McGarvey, Senior Vice President, Global Manufacturing Operations at Dexcom, said: “What makes Dexcom Athenry special is its people. We have already assembled a remarkable team of almost 500 people, the vast majority from right here in the West of
Notes to Editors
Dexcom currently employs almost 500 people at Athenry and continues to recruit additional employees across a range of disciplines. Further information on opportunities at Dexcom Athenry is available at careers.dexcom.com.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118656857/en/
Media Contact:
Gemma McDonald
gemma.mcdonald@dexcom.com
dexcomemea@allisonworldwide.com
Source: DexCom, Inc.